Skip to main content

FIRST TRUST ADVISORS LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1125816 Wheaton, IL

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$126,367,247
+$57,323,127 QoQ
Shares Held
959,217
+97.0% QoQ
Ownership
0.954%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

FIRST TRUST ADVISORS LP holds $590,881,836 across 26 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (21.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
959,217 $126,367,247

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $126,367,247 959,217
2025-12-31 $69,044,120 486,809
2025-09-30 $50,973,802 363,113
2025-06-30 $53,226,069 423,471
2025-03-31 $65,625,063 593,355
2024-12-31 $53,869,998 394,652
2024-09-30 $62,716,665 544,321
2024-06-30 $59,685,038 433,537
2024-03-31 $72,626,188 526,582
2023-12-31 $77,833,925 590,725
2023-09-30 $52,159,500 463,640
2023-06-30 $50,062,361 530,884
2023-03-31 $68,223,899 674,016
2022-12-31 $80,468,877 673,718
2022-09-30 $81,225,903 764,767
2022-06-30 $55,734,384 571,752
2022-03-31 $60,043,031 640,459
2021-12-31 $50,847,512 597,012
2021-09-30 $65,053,163 678,273
2021-06-30 $63,020,052 647,555
2021-03-31 $63,602,083 654,006
2020-12-31 $61,157,763 638,057
2020-09-30 $81,186,830 844,289
2020-06-30 $104,558,392 857,036
2020-03-31 $81,216,615 938,378